Avid Bioservices Inc (CDMO)
10.50
+0.23
(+2.24%)
USD |
NASDAQ |
Nov 04, 12:53
Avid Bioservices Total Liabilities (Quarterly): 276.01M for July 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 276.01M |
| April 30, 2024 | 275.67M |
| January 31, 2024 | 275.06M |
| October 31, 2023 | 270.97M |
| July 31, 2023 | 251.74M |
| April 30, 2023 | 262.40M |
| January 31, 2023 | 265.04M |
| October 31, 2022 | 260.66M |
| July 31, 2022 | 272.22M |
| April 30, 2022 | 255.32M |
| January 31, 2022 | 257.52M |
| October 31, 2021 | 250.52M |
| July 31, 2021 | 225.90M |
| April 30, 2021 | 187.77M |
| January 31, 2021 | 82.81M |
| October 31, 2020 | 64.21M |
| July 31, 2020 | 59.02M |
| April 30, 2020 | 65.72M |
| January 31, 2020 | 58.14M |
| October 31, 2019 | 56.07M |
| July 31, 2019 | 52.39M |
| April 30, 2019 | 25.33M |
| January 31, 2019 | 23.05M |
| October 31, 2018 | 25.43M |
| July 31, 2018 | 27.96M |
| Date | Value |
|---|---|
| April 30, 2018 | 40.02M |
| January 31, 2018 | 38.34M |
| October 31, 2017 | 35.72M |
| July 31, 2017 | 44.27M |
| April 30, 2017 | 64.53M |
| January 31, 2017 | 71.30M |
| October 31, 2016 | 67.76M |
| July 31, 2016 | 64.67M |
| April 30, 2016 | 58.97M |
| January 31, 2016 | 59.12M |
| October 31, 2015 | 43.43M |
| July 31, 2015 | 36.59M |
| April 30, 2015 | 38.43M |
| January 31, 2015 | 29.33M |
| October 31, 2014 | 22.66M |
| July 31, 2014 | 22.02M |
| April 30, 2014 | 22.85M |
| January 31, 2014 | 21.41M |
| October 31, 2013 | 19.46M |
| July 31, 2013 | 20.78M |
| April 30, 2013 | 21.30M |
| January 31, 2013 | 19.76M |
| October 31, 2012 | 23.86M |
| July 31, 2012 | 27.58M |
| April 30, 2012 | 18.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
58.14M
Minimum
Jan 2020
276.01M
Maximum
Jul 2024
206.14M
Average
255.32M
Median
Apr 2022
Total Liabilities (Quarterly) Benchmarks
| MEI Pharma Inc | 8.355M |
| Altimmune Inc | 20.82M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 334.64M |
| Shareholders Equity (Quarterly) | 58.64M |
| Debt to Equity Ratio | 2.624 |
| Current Ratio | 1.458 |
| Net Debt Paydown Yield | -0.40% |